Trial · NCT03118739
Results by group168
Each measurement the trial posted, group by group, in the words and numbers it posted.
101 to 120 of 168
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| MRI Variables - Diastolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate and Systolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate | Verinurad 9 mg+Febuxostat 80 mg | Systolic Circumferential Strain Rate (s^-1) (CFB) | 0.0115 | Standard Deviation 0.11314 | s^-1 |
| MRI Variables - Diastolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate and Systolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate | Placebo | Systolic Circumferential Strain Rate (s^-1) (CFB) | -0.0743 | Standard Deviation 0.11616 | s^-1 |
| MRI Variables - Diastolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate and Systolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate | Verinurad 9 mg+Febuxostat 80 mg | Systolic Longitudinal Strain Rate (s^-1) (CFB) | 0.0285 | Standard Deviation 0.08436 | s^-1 |
| MRI Variables - Diastolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate and Systolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate | Placebo | Systolic Longitudinal Strain Rate (s^-1) (CFB) | -0.0021 | Standard Deviation 0.08052 | s^-1 |
| MRI Variables - Diastolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate and Systolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate | Verinurad 9 mg+Febuxostat 80 mg | Systolic Radial Strain Rate (s^-1) (CFB) | -0.1917 | Standard Deviation 0.31833 | s^-1 |
| MRI Variables - Diastolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate and Systolic Circumferential Strain Rate, Longitudinal Strain Rate, Radial Strain Rate | Placebo | Systolic Radial Strain Rate (s^-1) (CFB) | 0.2516 | Standard Deviation 0.38049 | s^-1 |
| MRI Variables - LV Mass | Verinurad 9 mg+Febuxostat 80 mg | 1.80 | Standard Deviation 7.532 | g | |
| MRI Variables - LV Mass | Placebo | 2.63 | Standard Deviation 9.994 | g | |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Baseline Protein/Creatinine, mg/g | 945.56 | Standard Deviation 1457.714 | mg/g |
| Urinalysis | Placebo | Baseline Protein/Creatinine, mg/g | 828.52 | Standard Deviation 987.671 | mg/g |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Protein/Creatinine, mg/g 12 weeks (CFB) | -185.33 | Standard Deviation 366.340 | mg/g |
| Urinalysis | Placebo | Protein/Creatinine, mg/g 12 weeks (CFB) | -155.44 | Standard Deviation 584.772 | mg/g |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Protein/Creatinine, mg/g 24 weeks (CFB) | -98.60 | Standard Deviation 397.778 | mg/g |
| Urinalysis | Placebo | Protein/Creatinine, mg/g 24 weeks (CFB) | 177.11 | Standard Deviation 1387.627 | mg/g |
| Clinical Chemistry Values | Verinurad 9 mg+Febuxostat 80 mg | Baseline Hemoglobin A1C/Hemoglobin, % | 8.14 | Standard Deviation 1.913 | % hemoglobin bound to glucose |
| Clinical Chemistry Values | Placebo | Baseline Hemoglobin A1C/Hemoglobin, % | 8.28 | Standard Deviation 2.025 | % hemoglobin bound to glucose |
| Clinical Chemistry Values | Verinurad 9 mg+Febuxostat 80 mg | Hemoglobin A1C/Hemoglobin, % 12 weeks (CFB) | 0.20 | Standard Deviation 1.399 | % hemoglobin bound to glucose |
| Clinical Chemistry Values | Placebo | Hemoglobin A1C/Hemoglobin, % 12 weeks (CFB) | 0.13 | Standard Deviation 1.159 | % hemoglobin bound to glucose |
| Clinical Chemistry Values | Verinurad 9 mg+Febuxostat 80 mg | Hemoglobin A1C/Hemoglobin, % 24 weeks (CFB) | -0.14 | Standard Deviation 0.884 | % hemoglobin bound to glucose |
| Clinical Chemistry Values | Placebo | Hemoglobin A1C/Hemoglobin, % 24 weeks (CFB) | 0.22 | Standard Deviation 1.863 | % hemoglobin bound to glucose |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03118739/results?page=6